Related references
Note: Only part of the references are listed.Multiple Sclerosis Lesions and Irreversible Brain Tissue Damage A Comparative Ultrahigh-Field Strength Magnetic Resonance Imaging Study
Tim Sinnecker et al.
ARCHIVES OF NEUROLOGY (2012)
Characterizing contrast-enhancing and re-enhancing lesions in multiple sclerosis
Z. Campbell et al.
NEUROLOGY (2012)
Diagnostic Criteria for Multiple Sclerosis: 2010 Revisions to the McDonald Criteria
Chris H. Polman et al.
ANNALS OF NEUROLOGY (2011)
Increased diffusivity in acute multiple sclerosis lesions predicts risk of black hole
R. T. Naismith et al.
NEUROLOGY (2010)
Exploring recombinant human erythropoietin in chronic progressive multiple sclerosis
Hannelore Ehrenreich et al.
BRAIN (2007)
The brain erythropoietin system and its potential for therapeutic exploitation in brain disease
M Hasselblatt et al.
JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY (2006)
Delayed administration of erythropoietin and its non-erythropoietic derivatives ameliorates chronic murine autoimmune encephalomyelitis
C Savino et al.
JOURNAL OF NEUROIMMUNOLOGY (2006)
Methylprednisolone neutralizes the beneficial effects of erythropoietin in experimental spinal cord injury
A Gorio et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
The mechanism of action of methylprednisolone in the treatment of multiple sclerosis
JS Sloka et al.
MULTIPLE SCLEROSIS JOURNAL (2005)
Erythropoietin treatment improves neurological functional recovery in EAE mice
J Zhang et al.
BRAIN RESEARCH (2005)
Recombinant erythropoietin down-regulates IL-6 and CXCR4 genes in TNF-alpha-treated primary cultures of human microvascular endothelial cells - Implications of multiple sclerosis
JR Avasarala et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2005)
Recombinant erythropoietin as a neuroprotective treatment: in vitro and in vivo models
S Juul
CLINICS IN PERINATOLOGY (2004)
Neuroprotective effects and intracellular signaling pathways of erythropoietin in a rat model of multiple sclerosis
MB Sättler et al.
CELL DEATH AND DIFFERENTIATION (2004)
Beneficial effect of erythropoietin on experimental allergic encephalomyelitis
WP Li et al.
ANNALS OF NEUROLOGY (2004)
A novel endogenous erythropoietin mediated pathway prevents axonal degeneration
SC Keswani et al.
ANNALS OF NEUROLOGY (2004)
Erythropoietin:: Novel approaches to neuroprotection in human brain disease
H Ehrenreich et al.
METABOLIC BRAIN DISEASE (2004)
Beta-interferon treatment does not always slow the progression of axonal injury in multiple sclerosis
A Parry et al.
JOURNAL OF NEUROLOGY (2003)
Erythropoietin exerts an anti-inflammatory effect on the CNS in a model of experimental autoimmune encephalomyelitis
D Agnello et al.
BRAIN RESEARCH (2002)
Erythropoietin prevents motor neuron apoptosis and neurologic disability in experimental spinal cord ischemic injury
M Celik et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions
JW Peterson et al.
ANNALS OF NEUROLOGY (2001)
Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress
AL Sirén et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury
ML Brines et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Steroids for multiple sclerosis and optic neuritis: a meta-analysis of randomized controlled clinical trials
F Brusaferri et al.
JOURNAL OF NEUROLOGY (2000)
Autoimmune encephalomyelitis ameliorated by AMPA antagonists
T Smith et al.
NATURE MEDICINE (2000)
Share Paper
